Korea accedes to Hague system

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Korea accedes to Hague system

Korea’s accession to the Hague system, which provides a single application for international industrial design filings, will come into effect on July 1

In an interview with Managing IP last year, Korean IP Office (KIPO) Commissioner Kim Young-min cited accession to the system as an important goal of the office.

The Hague system is one of the three international registration systems maintained by WIPO, though it is not as prominent as the Madrid Protocol for trade marks and the PCT for patents. Last year, the Hague system saw a 14.8% increase in filings, with a record 2,990 applications. By contrast, there were 46,829 Madrid filings last year and 205,300 PCT filings.

One reason for the lower numbers is that many large jurisdictions have not acceded to the system. Neither China, Japan nor the US have joined, though they are expected to do so shortly. According to KIPO, those three countries along with Korea account for 85% of the slightly less than 1 million industrial design applications filed in 2012.

Somewhat surprisingly, North Korea has been a signatory to the Hague agreement since 1992.

more from across site and SHARED ros bottom lb

More from across our site

Julia Bishop is director of IP at Twilio in the US
Hellberg is an IP director at Essity in Sweden
Teemu Itälä is head of legal and compliance for technology standards at Nokia in Finland
Palińska is the business & IP law lead at CD Projekt Red in Poland
Schwitulla is the head of litigation management at Nokia in Germany
David Degen is senior IP counsel at Novartis, Switzerland
Demetrio Roberto Cavicchia is an IP director at Angelini Pharma in Italy
Almeida is the IP group leader at Bosch in Brazil
Amanda Luz is brand protection manager - global at Adidas in the US
Samantak Ghosh is vice president of IP at Avere Therapeutics in the US
Gift this article